Shivam Autotech’s large NCD funding round is essentially a leveraged turnaround bet: it meaningfully improves liquidity and operating flexibility in the near term but also increases balance‑sheet risk if the turnaround does not sustain.

Key points, based on recent disclosures and rating notes:

1. Context – already on a high‑debt base

- Over the last 2–3 years, the company has raised multiple debt instruments:

- ~₹105 crore from Modulus Alternatives in FY23 (₹80 cr NCD + ₹25 cr OCD), mostly used for repayment of old debt, statutory dues and creditors. (scribd.com)

- Board approval for up to ₹100 crore rated, listed NCDs, of which ~₹99.9 crore was actually issued on 23 June 2025 (Series A & B) via private placement. (arihantcapital.com)

- Additional approval in August 2025 to issue up to ₹25 crore secured, unlisted, redeemable NCDs. (in.marketscreener.com)

- CARE’s January 2025 rating note flags a very weak financial risk profile and high leverage: overall gearing at 7.29x as on 31 March 2024, worsened from 4.10x due to continued losses and incremental NCD/OCD debt. (scribd.com)

Your “₹277 cr NCD” number is broadly in line with the cumulative scale of NCD/OCD/term‑debt raising now stacked on the balance sheet.

2. Near‑term positives from the NCD raise

Assuming this ₹277 crore (or similar sized) debt pool is primarily used as management and lenders have indicated (refinancing + working capital), the changes are:

- Liquidity relief and survival runway

- Replacing short‑term/high‑cost borrowings and overdue liabilities (lenders, creditors, statutory dues) with structured NCDs improves the maturity profile of debt and reduces immediate default risk. (scribd.com)

- Working‑capital support helps normalise production (earlier volumes were hit because funds came in late), which should help revenue and EBITDA stabilise if demand holds. (scribd.com)

- Operational continuity and potential scale‑up

- Auto‑component manufacturing is capital and working‑capital intensive; without this funding, the company risked under‑utilising plants, losing OEM orders and market share.

- With stable funds, the company can:

- Run plants at higher utilisation,

- Service key OEM customers on time,

- Invest modestly in tooling / product development where required.

- Improved bargaining power with banks/suppliers (if the plan is executed)

- A successfully placed large NCD issue plus an institutional investor on the credit side signals that at least one sophisticated lender is underwriting a turnaround thesis.

- If operating metrics improve, this can support rating stability or upgrades over time and better terms on future bank lines.

3. Structural risks this creates

This is not a clean equity recap; it is more leverage on an already weak base:

- High fixed interest burden

- NCDs typically carry higher coupons than bank term loans. The CARE note already highlights thin and volatile margins (PBILDT margin fell in FY24 vs FY23) and continuous losses. (scribd.com)

- If EBITDA recovery is slower than planned, interest coverage can remain stressed or even turn negative, raising default risk.

- Leverage remains very elevated

- With gearing already >7x as of March 2024 and additional NCDs subsequently issued, the balance sheet is extremely sensitive to any earnings shock. (scribd.com)

- In a downcycle (auto slowdown, input‑cost spike, OEM loss), high leverage can quickly translate into covenant breaches, rating downgrades or restructuring.

- Complex capital structure and tighter lender rights

- Some of the debentures are optionally convertible with investor rights such as board representation and affirmative voting on key matters. (tipranks.com)

- This improves governance discipline but also means lenders have strong control rights; in stress scenarios, that can limit management flexibility and may not always align with minority shareholders’ interests.

- Limited margin of safety for equity

- When a turnaround is funded largely by debt instead of equity, equity becomes a residual, high‑risk claim.

- If the plan works, equity can see disproportionate upside (classic “leveraged recovery” story). If it fails, recovery value can accrue mainly to secured debenture‑holders, not shareholders.

4. What realistically changes in the company’s future

Over the next 2–3 years, this NCD programme is likely to change the company’s trajectory in these ways:

- Base case (management succeeds) – illustrative scenario, not a forecast

- Debt is used largely for:

- Refinancing old high‑cost/short‑tenor loans,

- Clearing overdue creditors/statutory dues,

- Funding working capital to fully utilise capacity.

- Result:

- Revenue and capacity utilisation rise,

- EBITDA stabilises and interest coverage improves,

- Ratings either stabilise or improve, enabling cheaper future borrowing or even eventual equity raising at better valuations.

- Under this path, the NCD raise becomes a bridge to a sustainable restructuring, and equity can benefit significantly.

- Adverse case (turnaround fails) – also an example, not a prediction

- Demand disappoints or operational issues persist, so incremental EBITDA from extra funding is not enough to service the higher fixed interest.

- High leverage and tight covenants could trigger:

- Rating downgrades,

- Renegotiation with debenture‑holders,

- Potential dilution or value erosion for equity if lenders enforce rights or push for further structured instruments.

- In this scenario, the NCD raise only postpones stress and may worsen the eventual outcome for shareholders.

5. Key things to track going forward (for an investor’s assessment)

For any investor analysing Shivam Autotech post this funding, the focus should be on data, not just the headline “₹277 cr NCD” number:

- Trend in revenue and EBITDA over the next 3–4 quarters.

- Interest coverage (EBITDA/interest) and net‑debt/EBITDA – do they improve meaningfully post‑fundraise?

- Utilisation levels at major plants and order visibility from key OEM customers.

- Any changes in CARE or other credit ratings, and the commentary (especially on liquidity and covenants). (scribd.com)

- Disclosures on use of proceeds in annual report / quarterly filings – what portion is true growth capex vs refinancing and arrears. (arihantcapital.com)

In summary, the large NCD raise improves Shivam Autotech’s short‑term survival prospects and operating flexibility but also makes the company more leveraged and sensitive to execution risk. The “future of the company” will depend far more on whether management can convert this liquidity into sustainable profitability than on the fundraising headline itself.

If you have any further queries, please connect with us on 022-6290-10141 (Timings : 09.00 AM to 05.00 PM) or you can email us on info@cniinfoxchange.com